Melanie Hansen Living Memoirs Interview

Melanie shared her unique background with missionary work and her experiences working as a dental assistant in Nicaragua. Nicaragua is a country in Central America bordered by the Pacific and Caribbean seas. The primary languages found in Nicaragua include Spanish and many other indigenous languages, and half of Nicaraguans are Roman Catholic. Nicaragua is known for the Bosawás Biosphere Reserve, the second-largest rainforest in the Americas, and its vibrant agricultural economy. Nietschmann, B. , Walker, . Thomas W. , Parker, . Franklin D. , Arguello, . Rosendo and Orozco, . Manuel S. (2023, December 2). Nicaragua. Encyclopedia Britannica. https://www.britannica.com/place/Nicaragu

Diversity Day: Insight into high school students

High school students Utah and nearby states go to a Utah State traditional event called Diversity Day. Students learn more about college, about Utah State, and have the opportunity to interview for a scholarships. 166 students were surveyed to better understand their academic self-efficacy and their actual preparedness to attend college. Students were also asked about what is most important to them when selecting a college, as well as what they feel most prepared or lacked in preparation in their college preparation. Results of the predominantly ethnic minority students were compared to students who identify as white

Telerehabilitation for aphasia – protocol of a pragmatic, exploratory, pilot randomized controlled trial

Background The Cochrane review on the effectiveness of speech and language therapy for aphasia following stroke suggests intensity of therapy is a key predictor for outcome. Current aphasia services cannot provide intervention at the intensity observed within trial contexts because of resource limitations. Telerehabilitation could widen access to speech-language pathologists (SLPs) in geographically remote contexts and reduce the time spent on travel by the therapist and patient. The current academic literature within this field is in its infancy, with few trials of speech and language therapy (SLT) delivered by videoconference. Our pilot randomized controlled trial (RCT) will explore feasibility aspects and effectiveness of telerehabilitation for aphasia in addition to standard SLT. Method/design Our study is a pragmatic, exploratory, pilot randomized controlled trial, where participants will be randomized to a telerehabilitation group or a control group. Both groups receive standard SLT (usual care) but the telerehabilitation group receives an additional 5 h of telerehabilitation per week over 4 weeks through videoconference. This additional telerehabilitation focuses on spoken language with an emphasis on word naming. We aim to include 40 patients in each group, with inclusion criteria being aphasia any time post stroke. Participants will be assessed blindly at pre-randomization (baseline), and 4 weeks and 4 months after randomization. The primary endpoint is naming ability 3 months after the completed intervention, measured by the Norwegian Basic Aphasia Assessment (NGA) naming subtest. Secondary endpoints include other subtests of the NGA, the VAST (Verb and Sentence Test) subtest sentence production, Communicative Effectiveness Index (CETI) and the Stroke and Aphasia Quality of Life scale (SAQOL-39). Experiences of patients and SLPs with telerehabilitation are assessed using questionnaires and semi-structured interviews. Statistical between group comparisons will be in line with an intention-to-treat analysis. Discussion This pilot RCT of intensive language training by videoconference will contribute new scientific evidence to the field of aphasia telerehabilitation. Here, we describe our trial which will explore the feasibility of telerehabilitation for aphasia as an intervention, our choice of primary and secondary outcome measures and proposed analyses. Our trial will provide information for the development and delivery of future definitive RCTs. Trial registration ClinicalTrials.gov, ID: NCT02768922 . Registered on 11 May 2016. Last updated on 17 November 2017

Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.

Importance: Glucagon-like peptide-1 (GLP-1) receptor agonists are effective therapies for the treatment of type 2 diabetes and are all currently available as an injection. Objectives: To compare the effects of oral semaglutide with placebo (primary) and open-label subcutaneous semaglutide (secondary) on glycemic control in patients with type 2 diabetes. Design, Setting, and Patients: Phase 2, randomized, parallel-group, dosage-finding, 26-week trial with 5-week follow-up at 100 sites (hospital clinics, general practices, and clinical research centers) in 14 countries conducted between December 2013 and December 2014. Of 1106 participants assessed, 632 with type 2 diabetes and insufficient glycemic control using diet and exercise alone or a stable dose of metformin were randomized. Randomization was stratified by metformin use. Interventions: Once-daily oral semaglutide of 2.5 mg (n = 70), 5 mg (n = 70), 10 mg (n = 70), 20 mg (n = 70), 40-mg 4-week dose escalation (standard escalation; n = 71), 40-mg 8-week dose escalation (slow escalation; n = 70), 40-mg 2-week dose escalation (fast escalation, n = 70), oral placebo (n = 71; double-blind) or once-weekly subcutaneous semaglutide of 1.0 mg (n = 70) for 26 weeks. Main Outcomes and Measures: The primary end point was change in hemoglobin A1c (HbA1c) from baseline to week 26. Secondary end points included change from baseline in body weight and adverse events. Results: Baseline characteristics were comparable across treatment groups. Of the 632 randomized patients (mean age, 57.1 years [SD, 10.6]; men, 395 (62.7%); diabetes duration, 6.3 years [SD, 5.2]; body weight, 92.3 kg [SD, 16.8]; BMI, 31.7 [SD, 4.3]), 583 (92%) completed the trial. Mean change in HbA1c level from baseline to week 26 decreased with oral semaglutide (dosage-dependent range, -0.7% to -1.9%) and subcutaneous semaglutide (-1.9%) and placebo (-0.3%); oral semaglutide reductions were significant vs placebo (dosage-dependent estimated treatment difference [ETD] range for oral semaglutide vs placebo, -0.4% to -1.6%; P = .01 for 2.5 mg, Conclusions and Relevance: Among patients with type 2 diabetes, oral semaglutide resulted in better glycemic control than placebo over 26 weeks. These findings support phase 3 studies to assess longer-term and clinical outcomes, as well as safety. Trial Registration: clinicaltrials.gov Identifier: NCT01923181

Beginning and Small Acreage Farms: Nonmotorized Tool Selection

Farming on 2 acres or less can be challenging, especially when considering equipment selection. It is important to carefully consider the equipment options available. Tools should be cost-effective, task and operation appropriate, of high quality and durability, and provide labor savings. Appropriate equipment contributes to farm viability by enhancing labor efficiency and crop quality. This fact sheet briefly describes equipment beginning farmers commonly need or use on small farms

Celosia Cut Flower Production In Utah

Celosia is a warm-season annual that can be grown in a field or high tunnel in Utah. Transplant plugs after last frost in the field and 6 to 8 weeks before last frost in a high tunnel. Celosia benefit from trellising to promote straight stems and do best with moderate soil fertility and frequent harvesting. Peak harvest occurs from July – September in the field and begins nearly one month earlier in a high tunnel. Once established, celosia thrive in Utah’s hot summers and can be used in fresh or dried arrangements

Gullringen fra Fosse, Strandebarm

Sommeren 2021 fant Lars Haukås en fingerring av gull da han var i gang med dreneringsarbeid på Fosse i Strandebarm i Kvam herad. Med gravemaskin var det gravd en 50–60 cm dyp grøft langs en jordvei som fører ned til Fossvågen. Da grøften ble fylt igjen, oppdaget Haukås ringen i noe av jorden som var kastet opp fra grøften. Fingerringen lå ca. 20 meter fra flomålet/vannkanten av Fossvågen. Funnet ble raskt meldt inn til Vestland fylkeskommune og Universitetsmuseet, og begeistringen var stor, både på Fosse og i Bergen, for funnet var en gullfingerring av middelaldersk type